Skip to main content
. 2014 Dec 1;7(12):8833–8840.

Table 1.

Associations of combined miR-23a and miR-23b expression with the clinicopathological features of gastric cancer (GC)

Clinical features Case Number (%) miR-23a-high/miR-23b-high

(N, %) P
Age (years)
    < 58 50 (31.25) 20 (40.00) NS
    ≥ 58 110 (68.75) 40 (36.36)
Gender
    Male 108 (67.50) 42 (38.89) NS
    Female 52 (32.50) 18 (34.62)
Tumor size (cm)
    < 4 58 (36.25) 20 (34.48) NS
    ≥ 4 102 (63.75) 40 (39.22)
Lauren classification
    Diffuse type 99 (61.88) 35 (35.35) NS
    Intestinal type 61 (38.12) 25 (40.98)
Differentiation
    Well or moderate 58 (36.25) 22 (37.93) NS
    Poor 102 (63.75) 38 (37.25)
Lymph node metastasis
    Negative 100 (62.50) 20 (20.00) 0.008
    Positive 60 (37.50) 40 (66.67)
TNM stage
    I 16 (10.00) 0 (0.00) < 0.001
    II 40 (25.00) 6 (15.00)
    III 42 (26.25) 15 (35.71)
    IV 62 (38.75) 39 (62.90)
Depth of invasion
    Mucosa or submucosa 26 (16.25) 1 (3.85) 0.02
    Muscularis or subserosa 20 (12.50) 3 (15.00)
    Serosa 82 (51.25) 35 (42.68)
    Adjacent structure 32 (20.00) 21 (65.63)

Note: ‘NS’ refers to the difference without statistical significance.